Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hepatitis

Free Subscription 20.10.2025 2 BMC Gastroenterol 3 Hepatology 1 J Hepatol 2 J Infect Dis 1 J Med Virol 5 J Viral Hepat 1 J Virol 2 PLoS One 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. CHEN J, Zhou W, Chen C, Mi F, et al
   Global prevalence of chronic kidney disease and its influencing factors among chronic hepatitis B: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:725.
   PubMed         Abstract available
   
   
2. ZHAO J, Cheng J, Liang S, Guo W, et al
   Aberrant alternative splicing in alcoholic hepatitis: regulatory roles of RBPs and sQTLs.
   BMC Gastroenterol. 2025;25:728.
   PubMed         Abstract available
   
   

   
   Hepatology

3. SIDHU G
   When "remission" isn't enough: The unseen burden of autoimmune hepatitis.
   Hepatology. 2025;82:1037-1038.
   PubMed        
   
   
4. DANPANICHKUL P, Duangsonk K, Chen VL, Saokhieo P, et al
   Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.
   Hepatology. 2025;82:1274-1286.
   PubMed         Abstract available
   
   
5. YOUNOSSI ZM, de Avila L, Racila A, Nader F, et al
   Prevalence and predictors of cirrhosis and portal hypertension in the united states.
   Hepatology. 2025 Jan 29. doi: 10.1097/HEP.0000000000001243.
   PubMed         Abstract available
   
   

   
   J Hepatol

6. POLAT M, Wahlin S, Efe C
   Can Autoimmune Hepatitis be diagnosed and treated without liver biopsy?
   J Hepatol. 2025 Oct 10:S0168-8278(25)02552-8. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   

   
   J Infect Dis

7. CHEN J, Huang Z, Yang X, Yang Y, et al
   Predictors of Durable Hepatitis B Surface Antigen Loss After Pegylated Interferon-Based Therapy in Patients with Hepatitis B e Antigen-Negative Chronic Hepatitis B: A Multicenter Real-World Study.
   J Infect Dis. 2025;232:953-960.
   PubMed         Abstract available
   
   
8. DAWES BE, De La Mota-Peynado A, Rezende IM, Buyukcangaz EK, et al
   Rift Valley Fever Virus Infectivity in Milk Stored at a Wide Range of Temperatures.
   J Infect Dis. 2025;232:e661-e670.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. ABRESCIA N, Maddaloni A, D'Abbraccio M, Molinaro G, et al
   Hepatitis B Control in Italy: The 35-Year Impact of Universal Infant Vaccination and Lessons for Global Elimination.
   J Med Virol. 2025;97:e70646.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

10. BADIA L, Ciancio A, Distefano M, Izzi A, et al
    Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study.
    J Viral Hepat. 2025;32:e70097.
    PubMed         Abstract available
    
    
11. XIE T, Su M, Cai M, Zhao T, et al
    Real-World Study for Mother-To-Child Transmission of Hepatitis B in Guangdong Province, 2021-2023.
    J Viral Hepat. 2025;32:e70094.
    PubMed         Abstract available
    
    
12. HARDIE DR, Korsman SNJ, Valley-Omar Z, Petersen N, et al
    Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa.
    J Viral Hepat. 2025;32:e70095.
    PubMed         Abstract available
    
    
13. OLTMANNS C, Witte M, Wranke A, Deterding K, et al
    HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.
    J Viral Hepat. 2025;32:e70092.
    PubMed         Abstract available
    
    
14. GRANTZ KH, Cummings DAT, Romero LM, Astemborski J, et al
    Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling Study.
    J Viral Hepat. 2025;32:e70096.
    PubMed         Abstract available
    
    

    
    J Virol

15. YU X, Liu C-D, Shen S, Kim ES, et al
    Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPalpha.
    J Virol. 2025 Oct 13:e0150925. doi: 10.1128/jvi.01509.
    PubMed         Abstract available
    
    

    
    PLoS One

16. CHIVITE I, Guilera V, Callau P, Aguilo R, et al
    Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain.
    PLoS One. 2025;20:e0328464.
    PubMed         Abstract available
    
    
17. MA X, Bai R, Zhu Z, Wang T, et al
    Hepatotoxicity risk factors in HIV-infected MSM with HBV/HCV coinfections: A cohort study in Northwestern China.
    PLoS One. 2025;20:e0333371.
    PubMed         Abstract available
    
    

    
    Vaccine

18. RACCAGNI AR, Morsica G, Reali P, Lolatto R, et al
    Long-term protection and response to a booster dose after primary hepatitis B vaccination in people under pre-exposure prophylaxis for HIV infection.
    Vaccine. 2025;66:127825.
    PubMed         Abstract available
    
    
19. COLLINS C, Ratshisusu L, Modise LM, Simani OE, et al
    Hepatitis B virus infection and vaccine coverage among children living with HIV, HIV-exposed uninfected, and HIV-unexposed uninfected children in the Western Cape, South Africa.
    Vaccine. 2025;66:127843.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.